Synthesis and Biological Evaluation of a Lipophilic Vorinostat Prodrug
Navneet Thakur, Neha Bhardwaj, Sudesh Kumar Yadav, Ankit Saneja · 2026
Read Synthesis and Biological Evaluation of a Lipophilic Vorinostat Prodrug by Navneet Thakur, Neha Bhardwaj, Sudesh Kumar Yadav, Ankit Saneja (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13616466.txt.
Description
Navneet Thakur and co-authors rework a cancer drug to slip into cells with more ease, in a study from 2026. The drug, vorinostat, is used for a skin lymphoma and can fight other cancers. But it crosses cell walls poorly and breaks down fast, so its punch fades.
The team tied the drug to short fat chains, which made four new forms. Checks proved the forms were pure and as drawn. The best form killed lung and breast cancer cells with more force than the plain drug. It also sparked more cell death signs, more cell stress, and less cell spread in a scratch test. Blood tests showed the form slowly splits to free the true drug, as a prodrug should. Lab screens predict a better wall crossing too.
Catalog record
| CREATOR | Navneet Thakur, Neha Bhardwaj, Sudesh Kumar Yadav, Ankit Saneja |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |